157 related articles for article (PubMed ID: 17874277)
1. Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.
Greenblatt DY; Cayo M; Ning L; Jaskula-Sztul R; Haymart M; Kunnimalaiyaan M; Chen H
J Gastrointest Surg; 2007 Nov; 11(11):1515-20; discussion 1520. PubMed ID: 17874277
[TBL] [Abstract][Full Text] [Related]
2. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2009 Feb; 16(2):481-6. PubMed ID: 19030935
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
5. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
[TBL] [Abstract][Full Text] [Related]
6. Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.
Somnay YR; Dull BZ; Eide J; Jaskula-Sztul R; Chen H
Cancer Gene Ther; 2015 Oct; 22(10):496-505. PubMed ID: 26403073
[TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of Thioredoxin1 Is Involved in Death of Calu-6 Lung Cancer Cells Treated With Suberoyl Bishydroxamic Acid.
You BR; Park WH
J Cell Biochem; 2016 May; 117(5):1250-61. PubMed ID: 26460805
[TBL] [Abstract][Full Text] [Related]
8. Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells.
Kunnimalaiyaan M; Traeger K; Chen H
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G636-42. PubMed ID: 16160079
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells.
Yang X; Zhang N; Shi Z; Yang Z; Hu X
Mol Med Rep; 2015 Apr; 11(4):2908-12. PubMed ID: 25501628
[TBL] [Abstract][Full Text] [Related]
10. Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors.
Xiao X; Ning L; Chen H
Mol Cancer Ther; 2009 Feb; 8(2):350-6. PubMed ID: 19190121
[TBL] [Abstract][Full Text] [Related]
11. Suberoyl bishydroxamic acid inhibits the growth of A549 lung cancer cells via caspase-dependent apoptosis.
You BR; Park WH
Mol Cell Biochem; 2010 Nov; 344(1-2):203-10. PubMed ID: 20652372
[TBL] [Abstract][Full Text] [Related]
12. MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.
Chen JY; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
J Surg Res; 2010 Jan; 158(1):15-9. PubMed ID: 19765735
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
Surgery; 2008 Dec; 144(6):956-61; discussion 961-2. PubMed ID: 19041003
[TBL] [Abstract][Full Text] [Related]
16. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells.
Van Gompel JJ; Kunnimalaiyaan M; Holen K; Chen H
Mol Cancer Ther; 2005 Jun; 4(6):910-7. PubMed ID: 15956248
[TBL] [Abstract][Full Text] [Related]
17. Hesperetin, a potential therapy for carcinoid cancer.
Zarebczan B; Pinchot SN; Kunnimalaiyaan M; Chen H
Am J Surg; 2011 Mar; 201(3):329-32; discussion 333. PubMed ID: 21367373
[TBL] [Abstract][Full Text] [Related]
18. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
Shao N; Zou J; Li J; Chen F; Dai J; Qu X; Sun X; Ma D; Ji C
Leuk Lymphoma; 2012 Sep; 53(9):1769-78. PubMed ID: 22303878
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.
Pitt SC; Chen H; Kunnimalaiyaan M
Ann Surg Oncol; 2009 Oct; 16(10):2936-42. PubMed ID: 19588205
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
